Arrowhead Pharmaceuticals (ARWR) Retained Earnings (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Retained Earnings of -$1.7 billion for Q1 2026, down 8.31% on a QoQ basis from -$1.6 billion in Q4 2025, and down 39486.67% year-over-year from N/an in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Retained Earnings (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Retained Earnings history runs 17 years deep, the most recent figure standing at -$1.7 billion for Q1 2026.
- Quarterly Retained Earnings fell 39486.67% year-over-year to -$1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.7 billion (down 39486.67% YoY) and the FY2025 annual result came in at $6.4 million, up 100.4% from the prior year.
- Retained Earnings was -$1.7 billion for Q1 2026 at Arrowhead Pharmaceuticals, down from -$1.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $6.4 million in Q3 2025 and bottomed at -$1.8 billion in Q4 2024.
- A 5-year average of -$671.6 million and a median of -$1.3 million in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings sank 754333.82% — and 2025, when it jumped 100.4%.
- Arrowhead Pharmaceuticals' Retained Earnings stood at -$258000.0 in 2022, then plunged by 386.43% to -$1.3 million in 2023, then sank by 143215.38% to -$1.8 billion in 2024, then gained by 11.25% to -$1.6 billion in 2025, then fell by 8.31% to -$1.7 billion in 2026.
- Business Quant data shows ARWR's Retained Earnings at -$1.7 billion in Q1 2026, -$1.6 billion in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -1.73 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.73 Bn |
| Dec 31, 2025 | -1.60 Bn |
| Sep 30, 2025 | 6.44 Mn |
| Jun 30, 2025 | 5.36 Mn |
| Mar 31, 2025 | 4.39 Mn |
| Dec 31, 2024 | -1.80 Bn |
| Sep 30, 2024 | -1.63 Bn |
| Jun 30, 2024 | -1.45 Bn |
| Mar 31, 2024 | -1.28 Bn |
| Dec 31, 2023 | -1.26 Mn |
| Sep 30, 2023 | -1.03 Bn |
| Jun 30, 2023 | -916.35 Mn |
| Mar 31, 2023 | -332,000.00 |
| Dec 31, 2022 | -258,000.00 |
| Sep 30, 2022 | -136,000.00 |
| Jun 30, 2022 | -140,000.00 |
| Mar 31, 2022 | -107,000.00 |
| Dec 31, 2021 | -707.56 Mn |
| Sep 30, 2021 | -644.69 Mn |
| Jun 30, 2021 | -581.32 Mn |